Stocktwits on MSN
SLS stock jumps overnight: CEO doubles down on ‘steadfast’ confidence in AML drug and pushes for 20M share plan approval
The CEO reaffirmed confidence in the Phase 3 Regal trial evaluating GPS in AML, despite the study remaining blinded. ・Sellas expects clinical updates and Phase 2 readouts for its CDK9 inhibitor, ...
A study of 527 business owners and C-suite executives reveals that high-visibility CEOs attract 6.1 times more investor ...
Nonprofits with annual budgets of $25 million to $50 million are making the greatest progress toward closing the gender pay gap for CEOs, according to the latest “GuideStar Nonprofit Compensation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results